Business
Universal Ibogaine advises further on application for Management Cease Trade Order
(TheNewswire) Calgary, AB – December 2, 2025 – TheNewswire – U...
About this update from Universal Ibogaine Inc
[{"type":"text","content":"Universal Ibogaine advises further on application for Management Cease Trade Order\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, AB – December 2, 2025 –\n \n\n TheNewswire\n \n\n – Universal Ibogaine Inc.\n(\n \n\n TSXV:IBO\n \n\n ) (“\n \n\n UI\n \n\n ” or the “\n \n\n Company\n \n\n ”), a life sciences company with a\nmission to research and deliver medicalized ibogaine-centered\naddiction care, advises of the following additional points related to\nits prior News Release of November 25, 2025 regarding its application\nto the Alberta Securities Commission (the “\n \n\n ASC\n \n\n ”, the\nCompany’s Principal Regulator) for a Management Cease Trade Order\n(“\n \n\n MCTO\n \n\n ”):\n \n\n\n\n\n\n The Company is not currently subject to any insolvency\nproceedings;\n \n\n\n\n\n\n There is no other material information related to the\nCompany that has not already been generally disclosed;\n \n\n\n\n\n\n As was previously advised, UI requested the ASC to\napprove a temporary MCTO under National Policy 12-203 –\n \n\n Management Cease Trade Orders for\nContinuous Disclosure Defaults\n \n\n (“\n \n\n NP 12-203\n \n\n ”), which,\nif granted, will prohibit trading securities of the Company by the\nChief Executive Officer (“\n \n\n CEO\n \n\n ”) and Chief Financial Officer\n(“\n \n\n CFO\n \n\n ”, position currently vacant) of the Company until such\ntime as the MCTO has been revoked or varied, or until two full\nbusiness days after all the Required Filings (defined below) have been\nfiled on SEDAR+.\n \n\n\n\n The MCTO application has been made but there is no\nguarantee or assurance that the MCTO will be granted.  During the\nperiod in which the potential MCTO would be in effect, the general\npublic would continue to be able to trade in the Company’s listed\ncommon shares.\n \n\n\n\n\n\n The Company was unable\nto file its audited consolidated financial statements for the\nfinancial year ended July 31, 2025 (the “\n \n\n Financial Statements\n \n\n ”) and the related management’s discussion and analysis\n(the “\n \n\n MD&A\n \n\n ”) and CEO and CFO certificates for this period\n(collectiv...